APMD

16.0906.70%
MB

Michael B. Kelly

Chief Financial Officer

Mr. Michael B. Kelly is Chief Financial Officer of Apnimed, Inc. from June 2026. Mr. Kelly has an experience in the life sciences and healthcare sectors, with extensive expertise in investment banking, capital markets, strategic transactions and corporate finance. Mr. Kelly served as Managing Director and Global Co-Head of Healthcare Investment Banking at Cantor Fitzgerald, a private financial services firm, from November 2016 to June 2026. Prior to Cantor Fitzgerald, Mr. Kelly served as Managing Director, Life Sciences Investment Banking at RBC Capital Markets from January 2014 to November 2016. Previously, he served as a Director at Barclays Capital (NYSE: BCS) from April 2009 to January 2014 and as a Vice President at Citigroup (NYSE: C) from February 2007 to January 2009. Mr. Kelly received an MBA from the University of California Los Angeles Anderson School of Management in 2003 and a B.A. in Business Economics with an emphasis in Accounting from the University of California, Santa Barbara in 1996.

Positions